4d Molecular Therapeutics In shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in 4d Molecular Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including 4d Molecular Therapeutics In held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in 4d Molecular Therapeutics In by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $428k | 21k | 20.26 |
| 2023-09-30 | $269k | 21k | 12.73 |
| 2023-06-30 | $314k | 17k | 18.07 |
| 2023-03-31 | $299k | 17k | 17.19 |
| 2022-12-31 | $386k | 17k | 22.21 |
| 2022-09-30 | $140k | 17k | 8.04 |
| 2022-06-30 | $121k | 17k | 6.98 |
| 2022-03-31 | $263k | 17k | 15.12 |
| 2021-12-31 | $245k | 11k | 21.94 |
| 2021-09-30 | $215k | 8.0k | 26.97 |
| 2021-03-31 | $177k | 4.1k | 43.38 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors